• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌药物管理计划对一家高流行率医院碳青霉烯类耐药感染发生率的长期临床和生态影响

Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Infections in a High-Endemic Hospital.

作者信息

López-Viñau Teresa, Muñoz-Rosa Montserrat, Ruiz-Lara Lidia Mª, García-Martínez Lucrecia, Machuca Isabel, Gracia-Ahufinger Irene, Montero Rafael Ruiz, Castón Juan José, Cano Ángela, Ruiz-Arabi Elisa, Del Prado José Ramón, Salcedo Inmaculada, Martínez-Martínez Luis, Torre-Cisneros Julián

机构信息

Pharmacy Unit, Reina Sofia University Hospital, 14004 Cordoba, Spain.

Infectious Diseases Unit, Reina Sofia University Hospital, Maimonides. Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba (UCO), 14004 Cordoba, Spain.

出版信息

Antibiotics (Basel). 2024 Aug 23;13(9):792. doi: 10.3390/antibiotics13090792.

DOI:10.3390/antibiotics13090792
PMID:39334967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11429328/
Abstract

Carbapenem-resistant (CR-Kp) is currently a serious global concern. Antimicrobial stewardship programs (ASPs) are one of the key strategies to overcome this resistance. However, evidence about the long-term clinical and ecological impacts of ASPs is scarce. A multidisciplinary team conducted a multifaceted intervention in a CR-Kp endemic hospital over a 6-year period. We assessed the monthly long-term impacts of ASPs on carbapenem use, incidence density (ID), and crude death rates of hospital-acquired CR-Kp infections. Other variables potentially related to CR-Kp incidence and healthcare activity indicators were monitored. Carbapenem use showed a sustained reduction over the long term, with a difference of -66.19% (95% CI -87.03 to -45.34) between the expected pre-intervention trend consumption value and that obtained six years after starting the program. The ID of CR-Kp also decreased significantly and was maintained over the long term, with a relative reduction of -88.14% (95% CI; -100.4 to -75.85) at the end of the study period. The crude death rate of CR-Kp at 14 and 28 days decreased significantly after the intervention and remained steady after six years. Infection control indicator trends remained stable. This mixed ASP contributed to reducing the high incidence of infections and mortality rates of CR-Kp, achieving a sustained ecological and clinical effect.

摘要

耐碳青霉烯类(CR-Kp)目前是一个严重的全球问题。抗菌药物管理计划(ASPs)是克服这种耐药性的关键策略之一。然而,关于ASPs长期临床和生态影响的证据很少。一个多学科团队在一家CR-Kp流行医院进行了为期6年的多方面干预。我们评估了ASPs对碳青霉烯类药物使用、发病率密度(ID)和医院获得性CR-Kp感染粗死亡率的长期月度影响。监测了其他可能与CR-Kp发病率和医疗活动指标相关的变量。碳青霉烯类药物的使用长期持续减少,干预前预期趋势消费值与项目启动六年后获得的值之间的差异为-66.19%(95%CI -87.03至-45.34)。CR-Kp的ID也显著下降并长期维持,在研究期末相对降低了-88.14%(95%CI;-100.4至-75.85)。干预后,CR-Kp在14天和28天的粗死亡率显著下降,并在六年后保持稳定。感染控制指标趋势保持稳定。这种综合的ASPs有助于降低CR-Kp的高感染率和死亡率,实现持续的生态和临床效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d329/11429328/3c5d696148ab/antibiotics-13-00792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d329/11429328/083f8c3916f1/antibiotics-13-00792-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d329/11429328/3c5d696148ab/antibiotics-13-00792-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d329/11429328/083f8c3916f1/antibiotics-13-00792-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d329/11429328/3c5d696148ab/antibiotics-13-00792-g002.jpg

相似文献

1
Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Infections in a High-Endemic Hospital.抗菌药物管理计划对一家高流行率医院碳青霉烯类耐药感染发生率的长期临床和生态影响
Antibiotics (Basel). 2024 Aug 23;13(9):792. doi: 10.3390/antibiotics13090792.
2
Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis.抗菌药物管理计划对耐碳青霉烯类革兰氏阴性杆菌发病率的影响:一项中断时间序列分析
Antibiotics (Basel). 2021 May 16;10(5):586. doi: 10.3390/antibiotics10050586.
3
Reduced Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in Cardiac Surgery Patients after Implementation of an Antimicrobial Stewardship Project.抗菌管理项目实施后心脏手术患者耐碳青霉烯类肺炎克雷伯菌感染发生率降低
Antibiotics (Basel). 2019 Aug 28;8(3):132. doi: 10.3390/antibiotics8030132.
4
Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand.泰国一家大学医院抗菌药物使用量与耐碳青霉烯类大肠杆菌及耐碳青霉烯类肺炎克雷伯菌流行率之间的相关性
J Clin Pharm Ther. 2019 Apr;44(2):292-299. doi: 10.1111/jcpt.12791. Epub 2018 Dec 21.
5
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.同一流行都市地区医院内耐碳青霉烯类肺炎克雷伯菌血流感染的流行病学、管理和结局。
J Infect Public Health. 2018 Mar-Apr;11(2):171-177. doi: 10.1016/j.jiph.2017.06.003. Epub 2017 Jun 28.
6
Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.特定的抗菌药物管理干预措施是否会对革兰氏阴性杆菌的碳青霉烯类耐药性产生影响?一项多中心准实验性生态学研究:时间趋势分析和碳青霉烯酶的特征。
J Antimicrob Chemother. 2021 Jun 18;76(7):1928-1936. doi: 10.1093/jac/dkab073.
7
Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.患者发生外膜通透性改变和产 KPC 碳青霉烯类耐药肺炎克雷伯菌分离的危险因素:一项双病例对照研究结果。
Infection. 2013 Feb;41(1):61-7. doi: 10.1007/s15010-012-0354-2. Epub 2012 Oct 16.
8
Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020.耐碳青霉烯类肺炎克雷伯菌全球分离株的地理分布模式以及头孢他啶/阿维巴坦、美罗培南/伏巴拉坦和对照药物对这些分离株的活性:2020年抗菌药物检测领导力与监测(ATLAS)项目的结果
Int J Antimicrob Agents. 2022 Nov-Dec;60(5-6):106679. doi: 10.1016/j.ijantimicag.2022.106679. Epub 2022 Oct 12.
9
Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.耐碳青霉烯类肺炎克雷伯菌(CR-KP)感染对肾移植的影响。
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12757. Epub 2017 Sep 28.
10
Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients.血清抗体对感染患者中耐碳青霉烯类肺炎克雷伯菌的反应。
mSphere. 2021 Mar 3;6(2):e01335-20. doi: 10.1128/mSphere.01335-20.

引用本文的文献

1
Incidence, clinical and genomic trends of hospital- and Non-hospital-onset KPC-producing Klebsiella pneumoniae infections before and during the COVID-19 era: a ten-year interrupted time series study.COVID-19 时代之前及期间医院内和非医院内产 KPC 肺炎克雷伯菌感染的发病率、临床及基因组趋势:一项十年中断时间序列研究
Antimicrob Resist Infect Control. 2025 Aug 7;14(1):97. doi: 10.1186/s13756-025-01614-6.
2
Antimicrobial Stewardship Program (ASP) in General Hospital: An Essential Practice.综合医院抗菌药物管理计划(ASP):一项重要举措。
Antibiotics (Basel). 2024 Nov 21;13(12):1108. doi: 10.3390/antibiotics13121108.

本文引用的文献

1
General Overview of : Epidemiology and the Role of Siderophores in Its Pathogenicity.概论:流行病学及铁载体在其致病性中的作用
Biology (Basel). 2024 Jan 27;13(2):78. doi: 10.3390/biology13020078.
2
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.全球碳青霉烯类耐药革兰氏阴性菌的威胁
Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022.
3
Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem Resistant Gram-Negative Bacilli: An Interrupted Time-Series Analysis.
抗菌药物管理计划对耐碳青霉烯类革兰氏阴性杆菌发病率的影响:一项中断时间序列分析
Antibiotics (Basel). 2021 May 16;10(5):586. doi: 10.3390/antibiotics10050586.
4
The Effect of Antibiotic Restriction Programs on Prevalence of Antimicrobial Resistance: A Systematic Review and Meta-Analysis.抗生素限制计划对抗菌药物耐药性流行率的影响:一项系统评价和荟萃分析。
Open Forum Infect Dis. 2021 Feb 13;8(4):ofab070. doi: 10.1093/ofid/ofab070. eCollection 2021 Apr.
5
Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.特定的抗菌药物管理干预措施是否会对革兰氏阴性杆菌的碳青霉烯类耐药性产生影响?一项多中心准实验性生态学研究:时间趋势分析和碳青霉烯酶的特征。
J Antimicrob Chemother. 2021 Jun 18;76(7):1928-1936. doi: 10.1093/jac/dkab073.
6
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae.抗菌药物管理在预防产 KPC 肺炎克雷伯菌中的作用。
J Antimicrob Chemother. 2021 Jan 29;76(Suppl 1):i12-i18. doi: 10.1093/jac/dkaa493.
7
Long-Term Carbapenems Antimicrobial Stewardship Program.长期碳青霉烯类抗菌药物管理计划
Antibiotics (Basel). 2020 Dec 26;10(1):15. doi: 10.3390/antibiotics10010015.
8
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature.碳青霉烯类药物联合治疗新出现的头孢他啶/阿维巴坦耐药和碳青霉烯类敏感产 KPC 肺炎克雷伯菌感染的应用:1 例病例报告及文献复习。
J Glob Antimicrob Resist. 2020 Sep;22:9-12. doi: 10.1016/j.jgar.2019.11.007. Epub 2019 Nov 13.
9
External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance.碳青霉烯类耐药肺炎克雷伯菌菌血症队列中 INCREMENT-CPE 死亡率评分的外部验证:多粘菌素耐药的预后意义。
Int J Antimicrob Agents. 2019 Oct;54(4):442-448. doi: 10.1016/j.ijantimicag.2019.07.017. Epub 2019 Aug 1.
10
Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis.西班牙安达卢西亚公共卫生系统医院实施的抗菌药物管理项目(PIRASOA 项目)的结果:时间趋势分析的生态学研究。
Clin Microbiol Infect. 2020 Mar;26(3):358-365. doi: 10.1016/j.cmi.2019.07.009. Epub 2019 Jul 16.